BridgeMD
New treatment option for Breast Cancer
Official title Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer
ClinicalTrials.gov ID: NCT07467824
What this study is testing
- What it's testing
- Breast cancer (BC) is the most common cancer among women worldwide. Cancer treatments are associated with numerous adverse events that reduce patients' functionality and alter their clinical and molecular profiles.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Women who have a newly confirmed diagnosis of stage 0-III breast cancer.
- Age 18 to 65 years old with a body mass index between 18.5 and 35 kg m-².
- Have a medical indication for surgery or neoadjuvant systemic treatment (chemotherapy or hormone therapy) or radiotherapy.
- Be able to perform supervised physical exercise, as determined by prior medical assessment.
- Understand and voluntarily sign the written informed consent before the start of the study.
You likely can't join if
- Women with a diagnosis of metastatic breast cancer.
- Women with any medical condition that contraindicates physical exercise, such as severe cardiovascular disease, significant respiratory or kidney...
- Women with presence of serious uncontrolled comorbidities, such as decompensated diabetes, severe hypertension or acute psychiatric disorders, among...
- Women with severe functional limitations that prevent planned interventions from being performed (e.g., physical disabilities that compromise...
- Women who are pregnant, breastfeeding, or likely to become pregnant during the trial or who have inability to communicate.
The study team makes the final eligibility decision.
Where it's taking place
- Valladolid, Valladolid, Spain
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valladolid, Valladolid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.